دورية أكاديمية
أعرض في EDS

Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response

التفاصيل البيبلوغرافية
العنوان: Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response
المؤلفون: Mei, YanAff1, Aff2, Wang, XiumeiAff3, Aff4, Zhang, Ji, Liu, DanAff6, Aff7, Aff8, He, JunjieAff1, Aff6, Aff8, Huang, ChunliuAff3, Aff4, Liao, Jing, Wang, Yingzhao, Feng, YongyiAff3, Aff4, Li, Hongyu, Liu, Xiuying, Chen, Lingdan, Yi, Wei, Chen, Xi, Bai, Hong-Min, Wang, XinyuAff3, Aff4, Li, YiyiAff3, Aff4, Wang, LixiangAff3, Aff4, Liang, Zhigang, Ren, Xianwen, Qiu, Li, Hui, Yuan, Zhang, QinglingAff2, IDs43018023005989_cor23, Leng, QibinAff1, IDs43018023005989_cor24, Chen, JunAff3, Aff4, Aff16, Aff17, IDs43018023005989_cor25, Jia, GuangshuaiAff1, Aff6, Aff8, IDs43018023005989_cor26
المصدر: Nature Cancer. 4(9):1273-1291
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:26621347
DOI:10.1038/s43018-023-00598-9